12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

VB-111: Phase I data

In a U.S. Phase I trial in 27 patients, a single IV injection of VB-111 produced 1 partial response lasting for 12 months and 7 cases of...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >